Latest News about PFE
Recent news which mentions PFE
From Benzinga
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection
November 17, 2022
From Benzinga
2 Dirt Cheap Dividend Stocks to Buy Right Now
November 16, 2022
From Motley Fool
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting
November 15, 2022
From Benzinga
If You Invested $1,000 In The Tesla Bear Daily ETF At IPO, Here's How Much You'd Have Now
November 15, 2022
From Benzinga
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
From Benzinga
3 Stocks With Dividends of 3% or More to Buy on the Dip
November 14, 2022
From Motley Fool
3 Beaten-Down Stocks to Buy Right Now
November 12, 2022
From Motley Fool
These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk
November 11, 2022
From Benzinga
From MarketWatch
Is This Blue-Chip Dividend Stock a Buy?
November 11, 2022
From Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
November 11, 2022
From Motley Fool
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
November 10, 2022
From MarketWatch
This COVID-19 Vaccine Stock Has More to Offer
November 10, 2022
From Motley Fool
2 Top Healthcare Stocks to Buy Right Now
November 10, 2022
From Motley Fool
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
From Benzinga
From MarketWatch
Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January
November 09, 2022
From Benzinga
Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines
November 08, 2022
From MarketWatch
The 7 Best Pharma Stocks to Buy Now
November 08, 2022
From InvestorPlace
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.